Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05375643

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Led by Nadine McCleary, MD, MPH · Updated on 2025-11-05

210

Participants Needed

3

Research Sites

277 weeks

Total Duration

On this page

Sponsors

N

Nadine McCleary, MD, MPH

Lead Sponsor

B

Bristol-Myers Squibb

Collaborating Sponsor

AI-Summary

What this Trial Is About

SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire, and informational video.

CONDITIONS

Official Title

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult (age 18 years or older)
  • Black, Latinx, OR older adult (age 70 years or older)
  • Scheduled for a new patient consultation
  • Suspected or confirmed advanced malignancy requiring active treatment
  • Diagnosed with gastrointestinal, hematologic, or thoracic cancer
  • Patient at Dana-Farber Cancer Institute or its satellite locations at St. Elizabeth's Medical Center or Merrimack Valley
Not Eligible

You will not qualify if you...

  • Malignancy or former malignancy requiring only surveillance
  • Not continuing care at a participating Dana-Farber Cancer Institute site
  • Speaks a language other than English or Spanish
  • Unable to provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Dana Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Actively Recruiting

2

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center

Brighton, Massachusetts, United States, 02135

Actively Recruiting

3

Dana-Farber Cancer Instiute - Merrimack Valley

Methuen, Massachusetts, United States, 01844

Not Yet Recruiting

Loading map...

Research Team

N

Nadine J McCleary, MD MPH

CONTACT

N

Nadine J McCleary, MD MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here